CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company
CUMBERLAND PHARMACEUTICALS INC
Sign in to watch- Ticker
- CPIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- TN
- Entity type
- operating
- EIN
- 621765329
- Phone
- 615-255-0068
- Business address
- 1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 71 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-25 | Jones James Director | Grant or award | +2,500 | $1.71 | $4K | 41,646 |
| 2024-03-25 | Krogulski Kenneth Director | Grant or award | +6,500 | $1.71 | $11K | 277,843 |
| 2024-03-25 | Young Caroline Director | Grant or award | +2,500 | $1.71 | $4K | 31,318 |
| 2024-03-25 | Krogulski Kenneth Director | Grant or award | +5,000 | $1.71 | $9K | 241,277 |
| 2024-03-25 | Jones James Director | Grant or award | +1,000 | $1.71 | $2K | 33,407 |
| 2024-03-25 | Galante Joseph C Director | Grant or award | +1,000 | $1.71 | $2K | 59,356 |
| 2024-03-25 | Young Caroline Director | Grant or award | +1,000 | $1.71 | $2K | 26,701 |
| 2024-03-25 | Brown Martin S JR Director | Grant or award | +1,000 | $1.71 | $2K | 6,000 |
| 2024-03-25 | KAZIMI A J Chairman and CEO | Grant or award · Options (right to buy) | +100,000 | 368,000 | ||
| 2024-03-25 | Herman James L VP and Chief Compliance Office | Grant or award · Options (right to buy) | +4,000 | $1.71 | $7K | 16,000 |
| 2024-03-25 | Bitterman Chris T. Vice Pres Sales & Marketing | Grant or award · Options (right to buy) | +2,750 | $1.71 | $5K | 13,250 |
| 2024-03-25 | Anthony Todd M. Vice Pres Organizational Dev | Grant or award · Options (right to buy) | +3,000 | $1.71 | $5K | 15,000 |
| 2024-03-25 | Hamm John M. VP Chief Financial Officer | Grant or award · Options (right to buy) | +5,500 | $1.71 | $9K | 12,500 |
| 2024-03-23 | KAZIMI A J Chairman and CEO | Shares withheld for taxes | −25,710 | $1.81 | $47K | 5,695,557 |
| 2024-03-23 | Herman James L VP and Chief Compliance Office | Shares withheld for taxes | −1,186 | $1.81 | $2K | 38,255 |
| 2024-03-23 | Bitterman Chris T. Vice Pres Sales & Marketing | Shares withheld for taxes | −593 | $1.81 | $1K | 4,683 |
| 2024-03-23 | Anthony Todd M. Vice Pres Organizational Dev | Shares withheld for taxes | −816 | $1.81 | $1K | 16,328 |
| 2024-03-23 | Hamm John M. VP Chief Financial Officer | Shares withheld for taxes | −445 | $1.81 | $805 | 26,003 |
| 2023-12-21 | Jones James Director | Other acquisition 10b5-1 | +87 | $1.70 | $148 | 32,407 |
| 2023-12-21 | Young Caroline Director | Other acquisition 10b5-1 | +87 | $1.70 | $148 | 25,701 |
Page 72 of 207 · 4,129 trades